LA SALUTE DEL SENO
http://www.breastcancercare.org.uk/breast-cancer-information/breast-awareness/being-breast-aware
http://www.breastcancercare.org.uk/breast-cancer-information/breast-awareness/being-breast-aware/changes-look-feel
PREVENZIONE PRIMARIA ALIMENTAZIONE E MOVIMENTO
Berrino F: Il cibo dellai??i??uomo. Milano, Franco Angeli, Milano, 2010.
Branchi A, Antonietti A, Quaglia J, Merlani G: Abitudini alimentari e di movimento dei giovani ticinesi: principali risultati dell’indagine sulla salute dei giovani ticinesi tra gli 11 e i 15 anni nel 2010.
DATI 2012; 12 (2): 53-61.
Linkare su: http://www4.ti.ch/fileadmin/DSS/DSP/UPVS/PDF/Pubblicazioni/DATI2012_HBSC_AlimMov.pdf
Lega svizzera contro il cancro: Consapevoli e sani: dieci suggerimenti della Lega svizzera contro il cancro.
Linkare su:Ai?? http://www.legacancro.ch/it/prevenzione_/movimento/
Pieth J, Navarra K, Grabherr M: Il movimento A? vita. Berna: Croce Rossa Svizzera, Scuola universitaria federale dello sport e Ufficio federale dello sport, 2008. Disponibile in 10 lingue: [linkare ai???Disponibile in 10 lingue ai??? su
http://www.migesplus.ch/it/pubblicazioni/alimentazione-movimento/show/il-movimento-e-vita-1/
SocietAi?? Svizzera di Nutrizione: Piramide alimentare svizzera: raccomandazioni alimentari per adulti che conciliano piacere ed equilibrio nellai??i??alimentazione. Berna: SSN: 2011.
Da linkare su:
http://www.sge-ssn.ch/it/io-e-te/mangiare-e-bere/in-modo-equilibrato/piramide-alimentare-svizzera/
Veronesi U: La grande sfida; sconfiggeremo il cancro con la prevenzione, la cura e la ricerca. Milano: RCS MediaGroup-Divisione quotidiani, 2013.
Villarini A, Allegro G: Prevenire i tumori mangiando con gusto. Milano: Sperling & Kupfer Editori, 2011.
Villarini A, Di Gangi F: Scegli ciA? che mangi: guida ai cibi che aiutano a proteggere la salute. Milano: Sperling & Kupfer Editori, 2011.
World Cancer Research Fund, American Institute for Cancer Research:Food, nutrition, physical activity and the prevention of cancer: a global perspective. Washington, DC.: AIRC, 2007.
Riassunto del rapporto in 8 lingue (inglese, francese, tedesco, spagnolo etc.)
linkare su:
http://www.wcrf.org/int/research-we-fund/our-cancer-prevention-recommendations
Rapporto integrale ( in inglese)
linkare su:
http://www.wcrf.org/sites/default/files/Second-Expert-Report.pdf
CONTROLLI SENOLOGICI E SCREENING MAMMOGRAFICO
Dipartimento della sanitAi?? e della socialitAi?? , sezione sanitaria e Europa Donna della Svizzera Italiana: La mammografia, un aiuto per capire e per decidere. Dipartimento della sanitAi?? e della socialitAi??, Sezione sanitaria e Europa Donna, Sezione Svizzera Italiana, Bellinzona 2008, revisione testo 2009, http://www4.ti.ch/fileadmin/DSS/DSP/UPVS/PDF/Progetti/Mammografia_2010.pdf
Certification Protocol (European Reference Organisation for Quality Assured Breast Cancer Screening and Diagnostic Services).
www.euref.org
Swiss Cancer Screening: http://www.swisscancerscreening.ch/it
Centro Programma Screening Ticino: http://www4.ti.ch/dss/dsp/cpst/home/
Documenti informativi per la popolazione; Centro Programma Screening Ticino:
http://www4.ti.ch/dss/dsp/cpst/screening-mammografico/documenti-per-la-popolazione/
FATTORI DI RISCHIO
Cancer Australia, National Breast and Ovarian Cancer Centre: Breast cancer risk factors: a review of the evidence. National Breast and Ovarian Cancer Centre, Surry Hills, NSW, 2009.
Weir, R, Day, P, Ali W: Risk factors for breast cancer in women. NZHTA Report 2007; 10(2).
Genetic/familial high-risk assessment: breast and ovarian. National Comprehensive Cancer Network clinical practice guidelines in oncology (NCCN guidelines) version 2.2015.
BalmaAi??a J, DAi??ez O, Rubio IT, Cardoso F: ESMO Guidelines Working Group. BRCA in breast cancer: ESMO Clinical Practice Guidelines. Ann Oncol. 2011;22 Suppl 6:vi31-4
Profato JL, Arun BK: Genetic risk assessment for breast and gynecological malignancies. Curr Opin Obstet Gynecol. 2015;27(1):1-5.
Cuzick J, DeCensi A, Arun B e altri: Preventive therapy for breast cancer: a consensus statement. Lancet Oncol. 2011;12(5):496-503
Visvanathan K, Hurley P, Bantug E e altri: Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2013 Aug 10;31(23):2942-62
IL TUMORE DEL SENO
DIAGNOSI TIPI DI TUMORE
Makki J. Diversity of Breast Carcinoma: Histological Subtypes and Clinical Relevance.Clin Med Insights Pathol. 2015;8:23-31.
Ades F, Zardavas D, Bozovic-Spasojevic I e altri: Luminal B breast cancer: molecular characterization, clinical management, and future perspectives. J Clin Oncol. 2014;32(25):2794-803
Guiu S, Michiels S, AndrAi?? F e altri: Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement. Ann Oncol. 2012;23(12):2997-3006
Penault-Llorca F, Viale G: Pathological and molecular diagnosis of triple-negative breast cancer: a clinical perspective.Ann Oncol. 2012;23 Suppl 6:vi19-22
Stuart KE, Houssami N, Taylor R e altri: Long-term outcomes of ductal carcinoma in situ of the breast: a systematic review, meta-analysis and meta-regression analysis. BMC Cancer. 2015;15:890
Mitchell KB, Kuerer H: Ductal Carcinoma In Situ: Treatment Update and Current Trends. Curr Oncol Rep. 2015;17(11):48
Vatovec C, Erten MZ, Kolodinsky J e altri: Ductal carcinoma in situ: a brief review of treatment variation and impacts on patients and society. Crit Rev Eukaryot Gene Expr. 2014; 24(4):281-6
Staley H, McCallum I, Bruce J: Postoperative Tamoxifen for ductal carcinoma in situ: Cochrane systematic review and meta-analysis. Breast. 2014;23(5):546-51
Cutuli B, Bernier J, Poortmans P: Radiotherapy in DCIS, an underestimated benefit? Radiother Oncol. 2014l;112(1):1-8.
TRATTAMENTI ED EFFETTI COLLATERALI
TERAPIA CON I FARMACI
Coates AS, Winer EP, Goldhirsch A e altri: Tailoring therapies-improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015. Ann Oncol. 2015;26(8):1533-46.
Partridge AH, Pagani O, Abulkhair O e altri: First international consensus guidelines for breast cancer in young women (BCY1). Breast. 2014;23(3):209-20.
Biganzoli L, Wildiers H, Oakman C e altri: Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA). Lancet Oncol. 2012;13(4):e148-60
Cardoso F, Loibl S, Pagani O e altri: European Society of Breast Cancer Specialists. The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer. Eur J Cancer. 2012;48(18):3355-77
Senkus E, Kyriakides S, Ohno S e altri: ESMO Guidelines Committee. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26 Suppl 5:v8-30
Burstein HJ, Temin S, Anderson H e altri: Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update. J Clin Oncol. 2014;32(21):2255-69Loren AW, Mangu PB, Beck LN e altri. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31(19):2500-10.
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG): Peto R, Davies C, Godwin J e altri. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet. 2012 4;379(9814):432-44
Zagouri F, Liakou P, Bartsch R e altri: Discrepancies between ESMO and NCCN breast cancer guidelines: An appraisal. Breast. 2015 Aug;24(4):513-23.
EFFETTI COLLATERALI DEI TRATTAMENTI E CONSIGLI PRATICI
BC Cancer Agency. Managing symptoms and side effects in
http://www.bccancer.bc.ca/health-info/coping-with-cancer/managing-symptoms/hair-loss-appearance-changes
Helms Rebecca L. et al. 2008: Body image issues in women with breast cancer. Psychology, Health and Medicine. 13: 313-325.
BC Cancer Agency. Nutritional Guidelines for Symptom Management. Unwanted weight gain in:Ai?? http://www.bccancer.bc.ca/nutrition-site/Documents/UnwantedWeightGain.pdf
Lega svizzera contro il cancro:Ai??La terapia antitumorale ha cambiato il mio aspetto. Berna: LegaAi?? svizzera contro il cancro,2007 http://assets.krebsliga.ch/downloads/3020.pdf
Lemieux Julie et altri:Ai??Chemotherapy-induced alopecia and effects on quality of life among women with breast cancer: a literature review. Psycho-Oncology 17: 317-328.2008
Gallagher P. et altri. 2009: Experience in the provision, fitting and supply of external breast protheses: findings from a national survey. European journal of cancer care: 18: 556-568.
Lega svizzera contro il cancro:Ai??La protesi del seno: la scelta giusta. Berna: LegaAi?? svizzera contro il cancro inAi?? http://assets.krebsliga.ch/downloads/3401.pd 2010
DURANTE E DOPO I TRATTAMENTI
CONTROLLI
Khatcheressian JL, Hurley P, Bantug E e altri: American Society of Clinical Oncology. Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31(7):961-5
Ferzoco RM, Ruddy KJ: Optimal delivery of male breast cancer follow-up care: improving outcomes. Breast Cancer (Dove Med Press). 2015;7:371-9.
GRAVIDANZA
Peccatori FA, Azim HA Jr, Orecchia R e altri: ESMO Guidelines Working Group. Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24 Suppl 6:vi160-70.
Pagani O, Partridge A, Korde L e altri: Breast International Group; North American Breast Cancer Group Endocrine Working Group. Pregnancy after breast cancer: if you wish, ma’am. Breast Cancer Res Treat. 2011 Sep;129(2):309-17
Loren AW, Mangu PB, Beck LN e altri: Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31(19):2500-10.
QUANDO LA MALATTIA SI RIPRESENTA
Senkus E, Cardoso F, Pagani O: Time for more optimism in metastatic breast cancer? Cancer Treat Rev. 2014 Mar;40(2):220-8
Cardoso F, Costa A, Norton L e altri:European School of Oncology; European Society of Medical Oncology. ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2). Breast. 2014;23(5):489-502.
McCutcheon S, Cardoso F: Challenges in optimizing care in advanced breast cancer patients: Results of an international survey linked to the ABC1 consensus conference. Breast. 2015;24(5):623-9.
Cardoso F, Harbeck N, Fallowfield L e altri: ESMO Guidelines Working Group. Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012 Oct;23 Suppl 7:vii11-9
Partridge AH, Pagani O, Abulkhair O e altri: First international consensus guidelines for breast cancer in young women (BCY1). Breast. 2014;23(3):209-20.
Gradishar WJ: Optimizing Treatment of HER2-Positive Breast Cancer. J Natl Compr Canc Netw. 2015;13(5 Suppl):649-51
Lin NU, Thomssen C, Cardoso F e altri: European School of Oncology-Metastatic Breast Cancer Task Force. International guidelines for management of metastatic breast cancer (MBC) from the European School of Oncology (ESO)-MBC Task Force: Surveillance, staging, and evaluation of patients with early-stage and metastatic breast cancer. Breast. 2013; 22(3):203-10
Carlson RW, Allred DC, Anderson BO e altri: National Comprehensive Cancer Network. Metastatic breast cancer, version 1.2012: featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2012;10(7):821-9
Biganzoli L, Wildiers H, Oakman C e altri: Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA). Lancet Oncol. 2012;13(4):e148-60
IL TUMORE DEL SENO MASCHILE
PDQ Adult Treatment Editorial Board: Male Breast Cancer Treatment (PDQAi??): Health Professional Version. PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-2016 Feb 4.
Sousa B, Moser E, Cardoso F: An update on male breast cancer and future directions for research and treatment. Eur J Pharmacol. 2013 Oct 5;717(1-3):71-83
Cardoso F, Costa A, Norton L e altri:European School of Oncology; European Society of Medical Oncology. ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2). Breast. 2014;23(5):489-502.
Senkus E, Kyriakides S, Ohno S e altri: ESMO Guidelines Committee. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26 Suppl 5:v8-30
Korde LA, Zujewski JA, Kamin L e altri: Multidisciplinary meeting on male breast cancer: summary and research recommendations. J Clin Oncol. 2010 Apr 20;28(12):2114-22
RICERCA CLINICA
World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects
http://www.who.int/bulletin/archives/79(4)373.pdf
Partecipasalute Partecipa alla ricerca
http://www.partecipasalute.it/cms_2/partecipa_alla_ricerca
Ecranproject – European Communication on Research Awareness Needs
http://www.ecranproject.eu/it
Swissmedic Sperimentazioni cliniche Leggi applicabili
https://www.swissmedic.ch/bewilligungen/00155/00242/index.html?lang=it